Related Experiment Video

Updated: Sep 25, 2026

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays
08:39

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays

Published on: January 3, 2015

[Down-regulation of vascular endothelial growth factor expression in ovarian cancer cell line SKOV3 by

Fang-fang Lin1, Huai-zeng Chen, Xing Xie

  • 1Department of Obstetrics, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China.

Zhonghua Fu Chan Ke Za Zhi
|June 21, 2003
PubMed
Abstract

Insights

Interferon-gamma (IFN-gamma) inhibits vascular endothelial growth factor (VEGF) expression in ovarian cancer cells. This study shows reduced VEGF mRNA and protein levels in SKOV3 cells treated with IFN-gamma.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Context:

  • Ovarian cancer is a leading cause of cancer-related death in women.
  • Vascular Endothelial Growth Factor (VEGF) plays a crucial role in tumor angiogenesis and progression.
  • Interferon-gamma (IFN-gamma) is a cytokine with known immunomodulatory and anti-tumor properties.

Purpose:

  • To investigate the effect of IFN-gamma on VEGF expression in the SKOV3 ovarian cancer cell line.
  • To quantify changes in VEGF at both mRNA and protein levels.

Summary:

  • SKOV3 cells were treated with varying concentrations and durations of IFN-gamma.
  • No significant changes in cell morphology or proliferation were observed.
  • IFN-gamma treatment led to a dose-dependent decrease in VEGF mRNA and protein expression.
  • Optimal inhibition was observed at 1,000 U/ml IFN-gamma, with no clear time-dependent effect.

Impact:

  • Demonstrates that IFN-gamma can suppress VEGF production in ovarian cancer cells.
  • Suggests a potential therapeutic strategy for targeting angiogenesis in ovarian cancer.
  • Provides a basis for further research into IFN-gamma's role in ovarian cancer treatment.

More Related Videos

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-107:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...